SEC Filing Summary: Amedica Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Amedica Corporation on September 9, 2015. The report addresses corporate governance updates rather than financial performance. Note: The request metadata references "Sintx Technologies, Inc.," but the filing text explicitly identifies the registrant as Amedica Corporation.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance metrics.
Material Changes
There are no material financial changes reported. The sole material event disclosed is the addition of Giuseppe Pezzotti, PhD to the company's Scientific Advisory Board.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document serves strictly to announce the personnel change via an attached press release (Exhibit 99.1).
Key Facts for Investor Verification
- Confirm the registrant name is Amedica Corporation, not Sintx Technologies, Inc.
- Verify the qualifications and background of Giuseppe Pezzotti, PhD, the new Scientific Advisory Board member.
- Review the attached press release (Exhibit 99.1) for details on the strategic rationale for this appointment.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial status.